Pdcd4-Rictor Interaction Suppresses PFKFB3 to inhibit Tumorigenesis

Area of Science:

• Oncology
• Molecular Biology
• Cellular Signaling

Background:

• Programmed cell death 4 (Pdcd4) is a known tumor suppressor and protein translation inhibitor.
• Emerging evidence suggests Pdcd4 has translation-independent functions in tumor suppression.

Purpose of the Study:

• To investigate the translation-independent mechanisms of Pdcd4 in tumor suppression.
• To elucidate the role of Pdcd4 in regulating mTORC2 signaling and glycolysis.

Main Methods:

• Deletion mapping and site-directed mutagenesis to identify Pdcd4-Rictor interaction domains.
• Co-immunoprecipitation and kinase assays to assess mTORC2 activity.
• Reverse phase protein array analysis to quantify protein levels.
• In vitro and in vivo (xenograft models) functional assays.

Main Results:

• Pdcd4 directly interacts with Rictor, a component of mTORC2, disrupting complex assembly and kinase activity.
• Pdcd4 binding to Rictor leads to the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) via ubiquitin-proteasome degradation.
• This Pdcd4-Rictor interaction suppresses glycolytic activity and inhibits tumor cell proliferation.
• Elevated Rictor and PFKFB3 levels correlate with non-small cell lung cancer (NSCLC) progression.

Conclusions:

• Pdcd4 suppresses NSCLC growth and glycolysis through a translation-independent mechanism.
• Disruption of mTORC2 signaling and subsequent downregulation of PFKFB3 by Pdcd4 is critical for tumor suppression.
• The Pdcd4-Rictor-PFKFB3 axis represents a potential therapeutic target for NSCLC.